Trials / Completed
CompletedNCT01243671
A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
A Multi-Center Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
To investigate efficacy, safety and pharmacokinetics of adalimumab subcutaneous (sc) for Japanese subjects with intestinal Behçet's disease who are refractory to conventional therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Adalimumab |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-03-01
- Completion
- 2013-06-01
- First posted
- 2010-11-18
- Last updated
- 2014-07-25
- Results posted
- 2013-05-15
Locations
12 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01243671. Inclusion in this directory is not an endorsement.